NCT06251154
Clinical Comparison of Two Soft Contact Lenses
A Clinical Comparison of Two Soft Contact Lenses (Iteration Under Umbrella Protocol C19-678)
Coopervision, Inc.·ClinicalTrials.gov·device·Device trialCompleted
View on ClinicalTrials.gov →Study focus
- Disease/Condition
- Myopia
- Drug/Device/Intervention
- Lens 1
- Study type
- Interventional
- Intervention type
- device
Sponsor & location
- Primary sponsor
- Coopervision, Inc.
- Location
- Manchester, United Kingdom
Timeline & enrollment
- Phase
- N/A
- Start date
- Dec 11, 2023
- End date
- Jan 08, 2024
- Enrollment
- 50 participants
Primary outcome
Subjective Overall Score
Summary
This study was designed to gather short-term clinical performance data for 2 soft contact
 lenses.
ICD-10 classifications
MyopiaDegenerative myopiaAmblyopia ex anopsiaOcular myiasisMyiasis
Data source
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06251154
- Type
- Device Trial
About this record
Access comprehensive clinical trial information for NCT06251154 through Pure Global AI's free database. This phase not specified trial is sponsored by Coopervision, Inc. and is currently Completed. The study focuses on Myopia. Target enrollment is 50 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.